Company News
Dr. Lal PathLabs Q1 FY27 Board Meeting Intimation
Board meeting scheduled for July 24, 2026 to approve unaudited Q1 FY27 standalone and consolidated financial results.
Trading window for company securities will be closed from July 1, 2026 to July 26,
